-
1
-
-
0023752982
-
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
-
Huang ME, Ye YC, Chen SR, Chai J, Lu JX, Zhoa L, Gu LJ, Wang ZY. 1998. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572.
-
(1998)
Blood
, vol.72
, pp. 567-572
-
-
Huang, M.E.1
Ye, Y.C.2
Chen, S.R.3
Chai, J.4
Lu, J.X.5
Zhoa, L.6
Gu, L.J.7
Wang, Z.Y.8
-
2
-
-
0025201879
-
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clin results
-
Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. 1990. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clin results Blood 76:1704-1709.
-
(1990)
Blood
, vol.76
, pp. 1704-1709
-
-
Castaigne, S.1
Chomienne, C.2
Daniel, M.T.3
Ballerini, P.4
Berger, R.5
Fenaux, P.6
Degos, L.7
-
3
-
-
0026536835
-
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia
-
Muindi J, Frankel SR, Miller WH, Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP, Jr. 1992. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299-303.
-
(1992)
Blood
, vol.79
, pp. 299-303
-
-
Muindi, J.1
Frankel, S.R.2
Miller Jr., W.H.3
Jakubowski, A.4
Scheinberg, D.A.5
Young, C.W.6
Dmitrovsky, E.7
Warrell Jr., R.P.8
-
4
-
-
0028109056
-
Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid
-
Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G. 1994. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk Res 18:587-596.
-
(1994)
Leuk Res
, vol.18
, pp. 587-596
-
-
Mehta, K.1
Sadeghi, T.2
McQueen, T.3
Lopez-Berestein, G.4
-
5
-
-
0141541769
-
Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers
-
Ozpolat B, Lopez-Berestein G, Adamson P, Fu CJ, Williams AH. 2003. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Sci 6:292-301.
-
(2003)
J Pharm Sci
, vol.6
, pp. 292-301
-
-
Ozpolat, B.1
Lopez-Berestein, G.2
Adamson, P.3
Fu, C.J.4
Williams, A.H.5
-
6
-
-
0029933428
-
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid
-
Estey E, Thall PF, Mehta K, Rosenblum M, Brewer T, Jr, Simmons V, Cabanillas F, Kurzrock R, Lopez-Berestein G. 1996. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. Blood 87:3650-3654.
-
(1996)
Blood
, vol.87
, pp. 3650-3654
-
-
Estey, E.1
Thall, P.F.2
Mehta, K.3
Rosenblum, M.4
Brewer Jr., T.5
Simmons, V.6
Cabanillas, F.7
Kurzrock, R.8
Lopez-Berestein, G.9
-
7
-
-
0033215452
-
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia
-
Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M. 1999. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 94:2230-2235.
-
(1999)
Blood
, vol.94
, pp. 2230-2235
-
-
Estey, E.H.1
Giles, F.J.2
Kantarjian, H.3
O'Brien, S.4
Cortes, J.5
Freireich, E.J.6
Lopez-Berestein, G.7
Keating, M.8
-
8
-
-
0035169587
-
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
-
Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, Boehm K, Williams T. 2001. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 97:73-80.
-
(2001)
Blood
, vol.97
, pp. 73-80
-
-
Douer, D.1
Estey, E.2
Santillana, S.3
Bennett, J.M.4
Lopez-Bernstein, G.5
Boehm, K.6
Williams, T.7
-
9
-
-
0037190052
-
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid
-
Lim SJ, Kim CK. 2002. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 243:135-146.
-
(2002)
Int J Pharm
, vol.243
, pp. 135-146
-
-
Lim, S.J.1
Kim, C.K.2
-
10
-
-
2142808709
-
Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration
-
Hwang SR, Lim SJ, Park JS, Kim CK. 2004. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int J Pharm 276:175-183.
-
(2004)
Int J Pharm
, vol.276
, pp. 175-183
-
-
Hwang, S.R.1
Lim, S.J.2
Park, J.S.3
Kim, C.K.4
-
11
-
-
0025343062
-
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
-
Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. 1990. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693-1700.
-
(1990)
Cancer Res
, vol.50
, pp. 1693-1700
-
-
Yokoyama, M.1
Miyauchi, M.2
Yamada, N.3
Okano, T.4
Sakurai, Y.5
Kataoka, K.6
Inoue, S.7
-
12
-
-
0031722638
-
Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size
-
Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. 1998. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 55:219-229.
-
(1998)
J Control Release
, vol.55
, pp. 219-229
-
-
Yokoyama, M.1
Satoh, A.2
Sakurai, Y.3
Okano, T.4
Matsumura, Y.5
Kakizoe, T.6
Kataoka, K.7
-
13
-
-
0032803387
-
Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum (II) and poly(ethyleneglycol)- poly(α, β-aspartic acid) block copolymer in an aqueous medium
-
Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K. 1999. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum (II) and poly(ethyleneglycol)-poly(α, β-aspartic acid) block copolymer in an aqueous medium. Langmuir 15:377-383.
-
(1999)
Langmuir
, vol.15
, pp. 377-383
-
-
Nishiyama, N.1
Yokoyama, M.2
Aoyagi, T.3
Okano, T.4
Sakurai, Y.5
Kataoka, K.6
-
14
-
-
0026887072
-
Preparation of micelle-forming polymer-drug conjugates
-
Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto T, Kataoka K. 1992. Preparation of micelle-forming polymer-drug conjugates. Bioconjug Chem 3:295-301.
-
(1992)
Bioconjug Chem
, vol.3
, pp. 295-301
-
-
Yokoyama, M.1
Kwon, G.S.2
Okano, T.3
Sakurai, Y.4
Seto, T.5
Kataoka, K.6
-
15
-
-
19444372638
-
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting
-
Opanasopit P, Yokoyama M, Watanabe M, Kawano K, Maitani Y, Okano T. 2004. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 21:2001-2008.
-
(2004)
Pharm Res
, vol.21
, pp. 2001-2008
-
-
Opanasopit, P.1
Yokoyama, M.2
Watanabe, M.3
Kawano, K.4
Maitani, Y.5
Okano, T.6
-
16
-
-
0027793811
-
Controlled biodistribution of highly lipophilic drugs with various parenteral formulations
-
Takino T, Nakajima C, Takakura Y, Sezaki H, Hashida M. 1993. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J Drug Target 1:117-124.
-
(1993)
J Drug Target
, vol.1
, pp. 117-124
-
-
Takino, T.1
Nakajima, C.2
Takakura, Y.3
Sezaki, H.4
Hashida, M.5
-
17
-
-
10844291853
-
Biodistribution and pharmacokinetics of O-palmitoyl tilisolol, a lipophilic prodrug of tilisolol, after intravenous administration in rats
-
Kawakami S, Ohshima N, Hirayama R, Hirai M, Kitahara T, Sakaeda T, Mukai T, Nishida K, Nakamura J, Nakashima M, Sasaki H. 2002. Biodistribution and pharmacokinetics of O-palmitoyl tilisolol, a lipophilic prodrug of tilisolol, after intravenous administration in rats. Biol Pharm Bull 25:1072-1076.
-
(2002)
Biol Pharm Bull
, vol.25
, pp. 1072-1076
-
-
Kawakami, S.1
Ohshima, N.2
Hirayama, R.3
Hirai, M.4
Kitahara, T.5
Sakaeda, T.6
Mukai, T.7
Nishida, K.8
Nakamura, J.9
Nakashima, M.10
Sasaki, H.11
-
18
-
-
0034602604
-
Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting
-
Hattori Y, Kawakami S, Yamashita F, Hashida M. 2000. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J Control Release 69:369-377.
-
(2000)
J Control Release
, vol.69
, pp. 369-377
-
-
Hattori, Y.1
Kawakami, S.2
Yamashita, F.3
Hashida, M.4
-
20
-
-
0034672561
-
Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice
-
Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M. 2000. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 1524:258-265.
-
(2000)
Biochim Biophys Acta
, vol.1524
, pp. 258-265
-
-
Kawakami, S.1
Wong, J.2
Sato, A.3
Hattori, Y.4
Yamashita, F.5
Hashida, M.6
-
21
-
-
4644316820
-
Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin
-
Yokoyama M, Opanasopit P, Okano T, Kawano K, Maitani Y. 2004. Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target 12:373-384.
-
(2004)
J Drug Target
, vol.12
, pp. 373-384
-
-
Yokoyama, M.1
Opanasopit, P.2
Okano, T.3
Kawano, K.4
Maitani, Y.5
-
22
-
-
0034863374
-
Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes
-
Kawakami S, Yamamura K, Mukai T, Nishida K, Nakamura J, Sakaeda T, Nakashima M, Sasaki H. 2001. Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes. J Pharm Pharmacol 53:1157-1161.
-
(2001)
J Pharm Pharmacol
, vol.53
, pp. 1157-1161
-
-
Kawakami, S.1
Yamamura, K.2
Mukai, T.3
Nishida, K.4
Nakamura, J.5
Sakaeda, T.6
Nakashima, M.7
Sasaki, H.8
-
23
-
-
0002079949
-
Disposition and tumor localization of mitomycin C-dextran conjugates in mice
-
Takakura Y, Takagi A, Hashida M, Sezaki H. 1987, Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm Res 4:293-300.
-
(1987)
Pharm Res
, vol.4
, pp. 293-300
-
-
Takakura, Y.1
Takagi, A.2
Hashida, M.3
Sezaki, H.4
-
24
-
-
0035137053
-
Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs
-
Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M. 2001. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs. J Pharm Sci 90:105-113.
-
(2001)
J Pharm Sci
, vol.90
, pp. 105-113
-
-
Kawakami, S.1
Munakata, C.2
Fumoto, S.3
Yamashita, F.4
Hashida, M.5
-
25
-
-
0036909463
-
Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: Effect of lipid composition
-
Murao A, Nishikawa M, Managit C, Wong J, Kawakami S, Yamashita F, Hashida M. 2002. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: Effect of lipid composition. Pharm Res 19:1808-1814.
-
(2002)
Pharm Res
, vol.19
, pp. 1808-1814
-
-
Murao, A.1
Nishikawa, M.2
Managit, C.3
Wong, J.4
Kawakami, S.5
Yamashita, F.6
Hashida, M.7
-
26
-
-
0019324697
-
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro
-
Kirby C, Clarke J, Gregoriadis G. 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 186:591-598.
-
(1980)
Biochem J
, vol.186
, pp. 591-598
-
-
Kirby, C.1
Clarke, J.2
Gregoriadis, G.3
-
27
-
-
0019951707
-
Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components
-
Senior J, Gregoriadis G. 1982. Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components. Life Sci 30:2123-2136.
-
(1982)
Life Sci
, vol.30
, pp. 2123-2136
-
-
Senior, J.1
Gregoriadis, G.2
-
28
-
-
0028224099
-
Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes
-
Harashima H, Sakata K, Funato K, Kiwada H. 1994. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res 11:402-406.
-
(1994)
Pharm Res
, vol.11
, pp. 402-406
-
-
Harashima, H.1
Sakata, K.2
Funato, K.3
Kiwada, H.4
-
29
-
-
2942583952
-
Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach
-
Teshima M, Kawakami S, Nishida K, Nakamura J, Sakaeda T, Terazono H, Kitahara T, Nakashima M, Sasaki H. 2004. Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. J Control Release 97: 211-218.
-
(2004)
J Control Release
, vol.97
, pp. 211-218
-
-
Teshima, M.1
Kawakami, S.2
Nishida, K.3
Nakamura, J.4
Sakaeda, T.5
Terazono, H.6
Kitahara, T.7
Nakashima, M.8
Sasaki, H.9
-
30
-
-
1542298890
-
All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer
-
Jeong YI, Kang MK, Sun HS, Kang SS, Kim HW, Moon KS, Lee KJ, Kim SH, Jung S. 2004. All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer. Int J Pharm 273:95-107.
-
(2004)
Int J Pharm
, vol.273
, pp. 95-107
-
-
Jeong, Y.I.1
Kang, M.K.2
Sun, H.S.3
Kang, S.S.4
Kim, H.W.5
Moon, K.S.6
Lee, K.J.7
Kim, S.H.8
Jung, S.9
-
31
-
-
0031720914
-
Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype on different fractions of cultured fetal rat hepatocytes
-
Falasca L, Favale A, Gualandi G, Maietta G, Conti Devirgiliis L. 1998. Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype on different fractions of cultured fetal rat hepatocytes. Hepatology 28:727-737.
-
(1998)
Hepatology
, vol.28
, pp. 727-737
-
-
Falasca, L.1
Favale, A.2
Gualandi, G.3
Maietta, G.4
Conti Devirgiliis, L.5
-
32
-
-
0037055534
-
Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
-
Ohlmann CH, Jung C, Jaques G. 2002. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl) retinamide] sufficient for cancer therapy? Int J Cancer 100:520-526.
-
(2002)
Int J Cancer
, vol.100
, pp. 520-526
-
-
Ohlmann, C.H.1
Jung, C.2
Jaques, G.3
-
33
-
-
0041412857
-
Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft
-
Choi Y, Kim SY, Kim SH, Yang J, Park K, Byun Y. 2003. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 107:145-148.
-
(2003)
Int J Cancer
, vol.107
, pp. 145-148
-
-
Choi, Y.1
Kim, S.Y.2
Kim, S.H.3
Yang, J.4
Park, K.5
Byun, Y.6
-
34
-
-
0037838342
-
Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture
-
Shimizu K, Tamagawa K, Takahashi N, Takayama K, Maitani Y. 2003. Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture. Int J Pharm 258:45-53.
-
(2003)
Int J Pharm
, vol.258
, pp. 45-53
-
-
Shimizu, K.1
Tamagawa, K.2
Takahashi, N.3
Takayama, K.4
Maitani, Y.5
-
35
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smanes
-
Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smanes. Cancer Res 46:6387-6392.
-
(1986)
Cancer Res
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
|